These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8164355)

  • 21. Further studies on a new bioassay of progestational activity (traumatic deciduoma formation in immature rats).
    Madjerek ZS; Smit-Vis JH
    Acta Morphol Neerl Scand; 1977 Feb; 15(1):65-74. PubMed ID: 72488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The androgenicity of progestational agents.
    Lobo RA
    Int J Fertil; 1988; 33 Suppl():6-12. PubMed ID: 2908040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
    J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate.
    Tuba Z; Bardin CW; Dancsi A; Francsics-Czinege E; Molnár C; Csörgei J; Falkay G; Koide SS; Kumar N; Sundaram K; Dukát-Abrók V; Balogh G
    Steroids; 2000 May; 65(5):266-74. PubMed ID: 10751638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
    Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs.
    Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A
    J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
    Neumannová M; Kauppila A; Kivinen S; Vihko R
    Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contraception using normal dose progestins].
    Pelissier-langbort C
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1099-109. PubMed ID: 12266559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolism, structure and biological activity of sex steroids].
    Okada H
    Nihon Naibunpi Gakkai Zasshi; 1993 Feb; 69(2):67-79. PubMed ID: 8486204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of newer progestins for contraception.
    Sitruk-Ware R; Nath A
    Contraception; 2010 Nov; 82(5):410-7. PubMed ID: 20933114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progestins in the menopause in healthy women and breast cancer patients.
    Pasqualini JR
    Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of progesterone and progestational hormones on the mammary gland].
    Gorins A; Denis C
    Arch Anat Cytol Pathol; 1995; 43(1-2):28-35. PubMed ID: 7794024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medroxyprogesterone acetate acutely facilitates and sequentially inhibits sexual behavior in female rats.
    Pazol K; Northcutt KV; Wilson ME; Wallen K
    Horm Behav; 2006 Jan; 49(1):105-13. PubMed ID: 16095597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progestagens in contraception].
    Kuhl H
    Wien Med Wochenschr; 1987 Oct; 137(18-19):433-40. PubMed ID: 3318155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
    Rübig A
    Climacteric; 2003 Oct; 6 Suppl 3():49-54. PubMed ID: 15018248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progestogens].
    Irahara M; Matsuzaki T; Kuwahara A; Yasui T
    Nihon Rinsho; 2008 Jan; 66(1):111-6. PubMed ID: 18193550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.